EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Perirenal Fat in Disease Progression: From Inflammatory Mediator to Therapeutic Target

Eiji Kashiwagi

International Journal of Urology · 2025

DOI: 10.1111/iju.70158 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Urology, 2025. Verfasst von Eiji Kashiwagi. Beteiligte Einrichtung: Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. Hauptthemen laut MEDLINE: Intra-Abdominal Fat, Kidney, Inflammation Mediators, Adipose Tissue. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perirenal fat (PRF), the adipose tissue that encases the kidneys, has long been considered a passive energy reservoir and mechanical buffer. However, emerging evidence has identified PRF as a biologically active visceral fat depot that secretes adipocytokines, inflammatory mediators, and other bioactive molecules, and thereby contributes to the pathogenesis and progression of several systemic diseases. PRF is associated with renal cell carcinoma, cardiovascular disease, chronic kidney disease, obesity, and metabolic syndrome. In renal cell carcinoma, PRF thickness correlates positively with tumor stage and negatively with prognosis. In cardiovascular and renal disorders, PRF accumulation is linked to elevated blood pressure and impaired renal function. Furthermore, PRF promotes a pro‐inflammatory microenvironment that exacerbates chronic kidney disease and metabolic abnormalities. These findings underscore the clinical relevance of PRF, both as a diagnostic and prognostic marker and a potential target for therapeutic intervention. This review provides a comprehensive overview of the roles of PRF in disease development and progression and emphasizes its emerging significance in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intra-Abdominal FatKidneyInflammation MediatorsAdipose TissueHumansDisease ProgressionKidney NeoplasmsCarcinoma, Renal CellObesityRenal Insufficiency, ChronicMetabolic SyndromeCardiovascular DiseasesPrognosisAdipokines

Stichwörter der Autor:innen

adipocytokinescardiovascular diseasechronic kidney diseaseinflammationmetabolic syndromeperirenal fat

Substanzen

Inflammation MediatorsAdipokines

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kashiwagi, E. (2025). Perirenal Fat in Disease Progression: From Inflammatory Mediator to Therapeutic Target. International Journal of Urology. https://doi.org/10.1111/iju.70158

Vancouver

Kashiwagi E. Perirenal Fat in Disease Progression: From Inflammatory Mediator to Therapeutic Target. International Journal of Urology. 2025. doi:10.1111/iju.70158

BibTeX
@article{Kashiwagi2025,
  author = {Kashiwagi, Eiji},
  title = {Perirenal Fat in Disease Progression: From Inflammatory Mediator to Therapeutic Target},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.70158}
}
Kostenlos starten →